1 Winner and 4 Losers from This Week’s Earnings Storm

Neurocrine Biosciences Inc. (NASDAQ:NBIX) had a loss and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.18 in the quarter versus EPS of $-0.01 in the year-earlier quarter. Revenue Decreased 93.79% to $700,000 from the year-earlier quarter.

Neurocrine Biosciences Inc. reported adjusted EPS loss of $0.18 per share. By that measure, the company met the mean analyst estimate of $-0.18. It missed the average revenue estimate of $1.12 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

NBIX

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.09 in the quarter versus EPS of $-0.18 in the year-earlier quarter. Revenue Rose 8.22% to $2.37 million from the year-earlier quarter.

Arena Pharmaceuticals, Inc. reported adjusted EPS loss of $0.09 per share. By that measure, the company missed the mean analyst estimate of $0.11. It missed the average revenue estimate of $50.36 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ARNA

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 150% to $0.05 in the quarter versus EPS of $0.02 in the year-earlier quarter. Revenue Rose 0.39% to $10.3 million from the year-earlier quarter.

Cumberland Pharmaceuticals, Inc. reported adjusted EPS income of $0.05 per share. By that measure, the company met the mean analyst estimate of $0.05. It beat the average revenue estimate of $10 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CPIX

Vocera Communications Inc (NYSE:VCRA) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.07 in the quarter versus EPS of $0.06 in the year-earlier quarter. Revenue Decreased 3.07% to $22.41 million from the year-earlier quarter.

reported adjusted EPS loss of $0.07 per share. By that measure, the company missed the mean analyst estimate of $-0.02. It missed the average revenue estimate of $24.33 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

VCRA

Emergent BioSolutions, Inc. (NYSE:EBS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.22 in the quarter versus EPS of $-0.19 in the year-earlier quarter. Revenue Decreased 14.33% to $43.1 million from the year-earlier quarter.

Emergent BioSolutions, Inc. reported adjusted EPS loss of $0.22 per share. By that measure, the company missed the mean analyst estimate of $-0.14. It missed the average revenue estimate of $46.17 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

EBS

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , , ,  

More from The Cheat Sheet